ArticleDiseases (Basel, Switzerland)2019
Epidemiological Trends and Resistance Associated with
Article in Diseases (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.Annals of clinical microbiology and antimicrobials · 2024Pooled it
- Shifting Epidemiology ofJournal of clinical medicine · 2026Article
- Genomic phylogeny, taxonomic classification, genetic landscape, and antibiotic resistance of clinicalFrontiers in microbiology · 2026Article
- Microbiological profile and 30-day mortality outcomes in febrile neutropenia among solid malignancy patients: a multicentre retrospective study from resource-limited setting.Scientific reports · 2025Article
- Cytotoxic Effect of Stenotrophomonas maltophilia Isolated from Prostate and Bladder Cancer Patients in Iraq.Asian Pacific journal of cancer prevention : APJCP · 2024Article
- Susceptibility of clinical isolates of novel pathogenJAC-antimicrobial resistance · 2024Article
- Antibiotic utilization trends in Veterans Affairs patients withAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024Article
- Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.BMC infectious diseases · 2023Article
- The Activities of Antimicrobials AgainstInfection and drug resistance · 2023Article
- The Prognosis of Patients Tested Positive forInfection and drug resistance · 2023Article
- Risk Factors for Mortality in Patients withInfectious diseases & clinical microbiology · 2022Article
- Article
- Xanthogranulomatous Pyelonephritis Caused byPathogens (Basel, Switzerland) · 2022Article
- Prevalence of resistance genes and antibiotic resistance profile amongNew microbes and new infections · 2021Article
- Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country.Infectious agents and cancer · 2021Article
- Article
- It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2021Review
- Article
- Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics AgainstInfection and drug resistance · 2021Article
- Challenges to Early Discharge of Patients with Upper Urinary Tract Infections by ESBL Producers: TMP/SMX as a Step-Down Therapy for Shorter Hospitalization and Lower Costs.Infection and drug resistance · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.